Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04693793 · ClinicalTrials.gov registry record · NA
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 219
- Enrollment target
NCT04693793 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 219 participants.
The verdict
NCT04693793, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
Study Summary
This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dyspnea and and how the results of Janssen Pharmaceuticals' test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.
Interventions
- OTHER Education Materials and Janssen Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2022-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04693793
The ClinicalTrials.gov registry entry for NCT04693793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Education Materials and Janssen Test is the first listed.
NCT04693793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04693793 about?
NCT04693793 is a clinical study titled "Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath". This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dyspnea and and how the results of Janssen Pharmaceuticals' test change clinical decision making. To do...
What is the current status of trial NCT04693793?
This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2021-03-05. Estimated completion is 2022-10-15.
What interventions are being tested in trial NCT04693793?
The interventions under investigation include: Education Materials and Janssen Test (OTHER).
Who is sponsoring clinical trial NCT04693793?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.